PR Newswire·Oct 7, 2025, 8:30 AM ET

MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars

Cryoport Inc. (NASDAQ: CYRX) announced the unveiling of MVE Biological Solutions' integrated Condition Monitoring Solutions for its MVE SC 4/2 V & 4/3 V series dewars.
The new systems are powered by Tec4Med, another Cryoport company, & integrate either a SmartTag™ or CryoBeacon™ directly into dewar lids.
Collected data is managed via MVECloud™, a secure, FDA 21 CFR Part 11 & GAMP 5 compliant platform providing real-time alerts, visibility, & reporting.
The CryoBeacon is a long-range Bluetooth Low Energy (BLE) 5.0 device that logs internal temperatures as low as –200°C, ambient temperature, & humidity, with data retrievable via QR code scanning.
The MVE SmartTag features Long Term Evolution (LTE) connectivity, up to 120 days of battery life, & provides continuous visibility & alerts during transport or storage.
MVE President & CEO Mike Duich stated the integration simplifies monitoring, empowers customers with control, & marks the beginning of a future where every MVE product is smart & connected.
Cryoport Chairman & CEO Jerrell Shelton noted the launch extends MVE's market-leading position, enables subscription-based revenue, & aligns with Cryoport's strategy to provide advanced tools for managing biological materials.
Cryoport Inc. is a global provider of temperature-controlled supply chain solutions for the life sciences, headquartered in Nashville, Tennessee, with operations across the Americas, EMEA, & APAC.